Department of Health is fair to patients with osteoporosis
暂无分享,去创建一个
C. Cooper | J. Reeve | D. Barlow | David Reid
[1] C. Albanese,et al. Bone densitometry in the clinical practice , 1997, European Radiology.
[2] R. Recker,et al. Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis , 1996 .
[3] J Dequeker,et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. , 1995, The New England journal of medicine.
[4] J. Compston. Bone densitometry in clinical practice: Author’s reply , 1995 .
[5] C. Nelson-Piercy,et al. Is indicated after long term treatment with heparin , 1995, BMJ.
[6] J. Compston,et al. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (WHO Technical Report Series No 843) , 1995 .
[7] D J Barker,et al. Risk factors for hip fracture. , 1995, The New England journal of medicine.
[8] S. Cummings,et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. , 1995, The New England journal of medicine.
[9] Clinical indications for bone mass measurements , 1989 .